tirzepatide and bone loss Tirzepatide, a dual GLP-1 GIP receptor agonist, promotes in obese mice via gut microbial-related metabolites GLP-1s and bone loss! |

Supporting Nutrients To maximize the effectiveness of both compounds, consider incorporating supporting nutrients into your routine

Published evidence supporting combination therapy in weight loss is minimal

At the same time, startups like Supergut, Olipop, Poppi, and Uplift Food are targeting the market with their high-fibre foods

Common digestive side effects of tirzepatide When people search tirzepatide digestive issues, theyre usually describing a cluster of temporary symptoms that may include nausea, stomach upset, bloating, reflux/heartburn, constipation, or diarrhea

Coverage Differences by Plan Type Employer-Sponsored Plans Employer-sponsored plans are increasingly covering GLP-1s for weight management with a focus on outcomes-driven health benefits and overall employee well-being